Skip to content

Peer Support for Severe Mental Disorders

Randomized Controlled Trial of Peer to Peer Support for People With Severe Mental Disorders: Schizophrenia, Affective Disorders and Personality Disorders in Comparison to Standard Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02276469
Acronym
PEER
Enrollment
200
Registered
2014-10-28
Start date
2011-07-31
Completion date
2014-12-31
Last updated
2015-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Borderline Personality Disorder, Major Depression, Psychosis

Keywords

severe mental illness

Brief summary

The purpose of this study is to determine wether peer support is effective for the treatment of people with severe mental illness.

Detailed description

A randomized controlled multi center trial is conducted, where patients receive usual care in the control group and usual care with additional peer support for 6 month in the intervention group. Psychosocial outcome criteria are collected pre intervention, after 6 month intervention and at one year follow up. Days till hospitalization and days spent in hospital are collected for one year before recruitment and one year after recruitment.

Interventions

BEHAVIORALpeer support

peer support is delivered by persons with a severe mental illness after the experience of recovery and after absolving a one year education to support others on their way to recovery

Sponsors

German Federal Ministry of Education and Research
CollaboratorOTHER_GOV
Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of schizophrenia, unipolar depression, bipolar disorder, personality disorder

Exclusion criteria

* primary clinical diagnosis of addiction

Design outcomes

Primary

MeasureTime frameDescription
Change from Baseline in Self-Efficacy at 6 month1. Baseline; 6 month follow up (post intervention); twelve month followGeneral Self-Efficacy Scale; Self report Questionnaire; 10 Items

Secondary

MeasureTime frameDescription
Change from Baseline in Severity of illness at 6 and 12 month1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month followClinical observation: Clinical global impression
Change from Baseline in Illness management, Coping at 6 and 12 month1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month followSelf report questionnaire: Subjective sense of psychosis
Hospitalization in days of in-patient careone year before, until one year past interventionThe days of in patient care assessed from the clinical records
Change from Baseline in Psychosocial functioning at 6 and 12 month1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month followClinical observation: Global assessment of functioning DSM
Change from Baseline in Quality of life at 6 and 12 month1. Baseline; 2. Six month follow up (post intervention) 3. Twelve month followSelf report questionnaires: Modulares System zur Lebensqualität MSLQ-R
Service satisfaction after six month of interventionAfter six month interventionSelf report questionnaire: Client Satisfaction Questionnaire CSQ 8
Days to hospitalizationBaseline until 12 month follow upDays to hospitalization after the beginning of treatment assessed from the clinical records

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026